×
Humana SG&A Expenses 2012-2025 | HUM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Humana sg&a expenses for the twelve months ending December 31, 2025 were
$0M
, a
0% increase
year-over-year.
Humana annual sg&a expenses for 2025 were
$0B
, a
0% decline
from 2024.
Humana annual sg&a expenses for 2024 were
$0B
, a
0% decline
from 2023.
Humana annual sg&a expenses for 2023 were
$0B
, a
0% decline
from 2022.
View More
Humana SG&A Expenses 2012-2025 | HUM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Humana annual sg&a expenses for 2025 were
$0B
, a
0% decline
from 2024.
Humana annual sg&a expenses for 2024 were
$0B
, a
0% decline
from 2023.
Humana annual sg&a expenses for 2023 were
$0B
, a
0% decline
from 2022.
Related Stocks
Company Name
Market
Cap
UnitedHealth Group (UNH)
$276.2B
Cigna Group (CI)
$71.5B
Centene (CNC)
$18.3B
Molina Healthcare (MOH)
$7.6B
Select Medical Holdings (SEM)
$2B
Joint (JYNT)
$125M
Aethlon Medical (AEMD)
$3M